(MedPage Today) — First-line treatment of advanced acral melanoma with the PD-1 inhibitor toripalimab (Loqtorzi) resulted in a small but statistically significant increase in progression-free survival (PFS) compared with treatment with dacarbazine…
Source:
Read full article at www.medpagetoday.com
Medical Disclaimer:
This content is for informational and educational purposes only.
It does not replace professional medical advice.
(MedPage Today) -- Universal hepatitis B vaccination at birth is safe, effective, and protective for both individual and public health,...
(MedPage Today) -- Most women said they preferred clinic-based cervical cancer testing over at-home self-sampling, with demographics and life experiences...
(MedPage Today) -- Two analyses suggested that non-medical (illicit) gabapentin use persisted in recent years as patterns in prescribing shifted....
Colorectal cancer has long baffled scientists because, unlike most tumors, patients often do better when their cancers are packed with...
(MedPage Today) -- Further release of files related to the sex offender Jeffrey Epstein affirmed what we collectively suspected, despite...
(MedPage Today) -- People diagnosed with cancer during the first 2 years of the COVID-19 pandemic had worse short-term survival...
